Surajeet Das Gupta &Amp; Ruchika Chitravanshi

Stories by Surajeet Das Gupta &Amp; Ruchika Chitravanshi

'Vaccine is far safer than getting Covid'

'Vaccine is far safer than getting Covid'

Rediff.com   16 Jan 2021

'I would go for Bharat Biotech's Covaxin and not Covishield, and that is my personal judgment since at least 11,500 have got at least one dose by now and it has proven to be safe.'

How Sunil Vachani plans to take Dixon Tech global

How Sunil Vachani plans to take Dixon Tech global

Rediff.com   14 Jan 2021

Today, Vachani's public-listed company, Dixon Technologies, has gone beyond manufacturing just television sets. Armed with private equity funding from Motilal Oswal eight years ago, it has transformed itself into a Rs 4,400 crore electronic manufacturing services major, which now straddles lighting products, home appliances, feature phones, LED bulbs, amongst others. A two-part series looks at how two home-grown manufacturers are leveraging the govt's production-linked incentive scheme.

COVID-19 Vaccine: Vial, syringe makers ramp up

COVID-19 Vaccine: Vial, syringe makers ramp up

Rediff.com   2 Jan 2021

'The government should put the whole road map together for the vaccine and decide how industry can support...' 'They should allow the private sector to vaccinate.'

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

Rediff.com   31 Dec 2020

The expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine.

Nod for Covid vaccine in next few days: Serum Institute's Poonawalla

Nod for Covid vaccine in next few days: Serum Institute's Poonawalla

Rediff.com   29 Dec 2020

The Serum Institute of India has stockpiled 40 mn-50 mn doses and is adding more every week. Most of these will come to India.

Is Reliance Jio's 5G plan realistic?

Is Reliance Jio's 5G plan realistic?

Rediff.com   23 Dec 2020

Surajeet Das Gupta explains why Mukesh Ambani's target is by no means impossible.

'Unprecedented vaccine trial in India'

'Unprecedented vaccine trial in India'

Rediff.com   23 Dec 2020

Bharat Biotech recruited 13,000 participants for the Phase-3 clinical trial of Covaxin. This is one of the largest efficacy trials held in the country.

New rules will make Ola, Uber's life tougher

New rules will make Ola, Uber's life tougher

Rediff.com   22 Dec 2020

Just a few weeks ago, the Centre has come out with the long-awaited Motor Vehicle Aggregator Guidelines, which have drawn a dismayed response from the companies concerned.

Wistron: 'We made mistakes as we expanded'

Wistron: 'We made mistakes as we expanded'

Rediff.com   22 Dec 2020

iPhone SE 2020 is one of the popular phones like Apple 11, which is the biggest seller in the domestic market.

COVID-19: How to get vaccinated

COVID-19: How to get vaccinated

Rediff.com   19 Dec 2020

For vaccination, online registration is mandatory. Thereafter, eligible beneficiaries will be informed on their registered mobile number about the nearest vaccination facility, and the date and time of vaccination.

Sunil Mittal's $2 bn gamble on space

Sunil Mittal's $2 bn gamble on space

Rediff.com   18 Dec 2020

Bharti Global is planning to put up more satellites and has set a stiff deadline to launch commercial Internet services by October in the UK, Alaska, northern Russia and northern Europe.

Sovereign fund flow: India replaces China as most sought-after destination

Sovereign fund flow: India replaces China as most sought-after destination

Rediff.com   17 Dec 2020

In the year 2020 to date, these funds deployed capital worth a record $14.8 billion in India, which is nearly three times more than what they have put in China - $4.5 billion.

Will Reliance be real estate's new disruptor?

Will Reliance be real estate's new disruptor?

Rediff.com   16 Dec 2020

A stake sale of Reliance's real estate portfolio would help it raise anything between $1-5 billion and could be one of the triggers for the company's shares to break out.

More than 60% of bankruptcy proceedings led to liquidation in Q2

More than 60% of bankruptcy proceedings led to liquidation in Q2

Rediff.com   16 Dec 2020

Experts say this further underlines the lack of investor interest in stressed assets at present.

Sunil Mittal's son Shravin ups his reputation as VC investor

Sunil Mittal's son Shravin ups his reputation as VC investor

Rediff.com   10 Dec 2020

Shravin Mittal's venture capital firm, Unbound Advisors, has made investments worth over $500 million so far

Covid: How Pfizer plans to resolve cold storage issues in India

Covid: How Pfizer plans to resolve cold storage issues in India

Rediff.com   7 Dec 2020

The company has developed detailed logistical plans and tools to support effective vaccine transport, storage, and temperature monitoring. Sohini Das and Ruchika Chitravanshi report.

Why your mobile phones are likely to cost more

Why your mobile phones are likely to cost more

Rediff.com   3 Dec 2020

With supply of mobile chipsets running dry, manufacturers here are left with no option but to hike prices once again, making it the fourth round of increase in 2020.

Govt to decriminalise provisions of LLP Act

Govt to decriminalise provisions of LLP Act

Rediff.com   23 Nov 2020

One of the changes being proposed is allowing LLPs to issue non-convertible debentures.

Telcos want level-playing field with satellite companies

Telcos want level-playing field with satellite companies

Rediff.com   18 Nov 2020

The move comes a few days after billionaire businessman Elon Musk tweeted that his Starlink internet services would be available in India as soon as it gets regulatory approvals next year. Musk's Starlink, which plans to have a constellation of 40,000 low-orbit satellites, recently started offering high-speed internet in the US as part of its beta launch phase.

Covid-19 pandemic was a boon for online biz

Covid-19 pandemic was a boon for online biz

Rediff.com   17 Nov 2020

Education technology, grocery, fashion, food delivery and UPI payments surpassed volumes or revenues of February, in the September-October period.